Clariscan

Clariscan (Gadoteric Acid) is a contrast agent used in MRI scans to enhance image clarity. It is administered intravenously and is manufactured by GE Healthcare AS in the EU.

Clariscan is primarily used to improve the visibility of internal structures during magnetic resonance imaging (MRI). It helps in diagnosing various conditions by making abnormalities more apparent. The contrast agent is often used in what is Clariscan used for scenarios involving the detection of tumors, inflammation, or other irregularities in the body.

Clariscan works by temporarily altering the magnetic properties of tissues, which enhances the contrast in MRI images. This can make it easier for healthcare professionals to identify and assess areas of concern. Common effects include improved image clarity, which aids in accurate diagnosis.

Clariscan should be used with caution in individuals with a history of allergic reactions to contrast agents. It is important to inform healthcare providers about any existing medical conditions or allergies before administration. Proper handling and storage are essential to maintain the integrity of the product.

Clariscan may interact with certain medications or medical conditions. It is advisable to discuss all current medications with a healthcare provider before using this contrast agent. Additionally, individuals with kidney problems should be monitored closely, as contrast agents can affect renal function.